Go Pro

Nano-X Imaging (NNOX) Projected to Release Earnings on Wednesday

Nano-X Imaging logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Nano-X Imaging is expected to report Q2 2026 results before the market opens on September 9. Analysts forecast a loss of $0.162 per share on $5.376 million in revenue, compared with $4.31 million in revenue and a $0.16-per-share loss in the prior quarter.
  • The stock opened at $0.79 and remains near its 52-week low of $0.73, with a market capitalization of approximately $61.8 million. The company continues to report sharply negative profitability, including a net margin of -716.44%.
  • Analyst sentiment is mixed but averages to a “Moderate Buy” rating, with a consensus price target of $4.33. Meanwhile, company insiders bought 95,443 shares worth about $89,706 over the past three months.
  • Interested in Nano-X Imaging? Here are five stocks we like better.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) will likely be announcing its Q2 2026 results before the market opens on Wednesday, September 9th. Analysts expect Nano-X Imaging to post earnings of ($0.1620) per share and revenue of $5.3760 million for the quarter. Individuals may review the information on the company's upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 8:30 AM ET.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last announced its earnings results on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $4.31 million during the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Nano-X Imaging Price Performance

Nano-X Imaging stock opened at $0.79 on Wednesday. Nano-X Imaging has a fifty-two week low of $0.73 and a fifty-two week high of $4.71. The firm has a fifty day moving average price of $1.03 and a two-hundred day moving average price of $1.74. The firm has a market cap of $61.76 million, a price-to-earnings ratio of -0.50 and a beta of 1.26.

Wall Street Analysts Forecast Growth

NNOX has been the topic of a number of recent analyst reports. Zacks Research upgraded Nano-X Imaging from a "strong sell" rating to a "hold" rating in a research note on Monday, June 22nd. Cantor Fitzgerald restated an "overweight" rating and set a $5.00 target price on shares of Nano-X Imaging in a research note on Monday, August 17th. Alliance Global Partners lowered Nano-X Imaging from a "buy" rating to a "neutral" rating and lowered their target price for the company from $5.00 to $3.00 in a report on Tuesday, July 7th. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Nano-X Imaging in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Nano-X Imaging presently has an average rating of "Moderate Buy" and an average price target of $4.33.

Read Our Latest Report on Nano-X Imaging

Insider Transactions at Nano-X Imaging

In other Nano-X Imaging news, Director Dan S. Suesskind purchased 50,000 shares of the company's stock in a transaction that occurred on Monday, July 27th. The stock was purchased at an average price of $0.93 per share, with a total value of $46,500.00. Following the completion of the transaction, the director directly owned 50,000 shares of the company's stock, valued at approximately $46,500. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Erez Meltzer purchased 36,000 shares of the business's stock in a transaction on Monday, July 27th. The shares were acquired at an average price of $0.93 per share, with a total value of $33,480.00. Following the purchase, the chief executive officer owned 36,000 shares of the company's stock, valued at approximately $33,480. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders purchased 95,443 shares of company stock worth $89,706.

Hedge Funds Weigh In On Nano-X Imaging

A number of hedge funds have recently modified their holdings of the stock. Virtu Financial LLC lifted its position in shares of Nano-X Imaging by 26.4% during the 4th quarter. Virtu Financial LLC now owns 72,535 shares of the company's stock worth $203,000 after buying an additional 15,169 shares during the period. Millennium Management LLC bought a new stake in Nano-X Imaging in the fourth quarter valued at $91,000. Engineers Gate Manager LP grew its position in Nano-X Imaging by 272.2% in the fourth quarter. Engineers Gate Manager LP now owns 52,844 shares of the company's stock valued at $148,000 after acquiring an additional 38,648 shares during the period. Weiss Asset Management LP acquired a new position in Nano-X Imaging during the fourth quarter worth $8,424,000. Finally, Russell Investments Group Ltd. raised its stake in Nano-X Imaging by 49.0% during the fourth quarter. Russell Investments Group Ltd. now owns 20,541 shares of the company's stock worth $58,000 after acquiring an additional 6,754 shares in the last quarter. 21.49% of the stock is owned by institutional investors and hedge funds.

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.

Further Reading

Earnings History for Nano-X Imaging (NASDAQ:NNOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Nano-X Imaging Right Now?

Before you consider Nano-X Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.

While Nano-X Imaging currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines